(secondQuint)A Study of Chemoradiotherapy Using Gem Plus Nab-paclitaxel for Pancreatic Cancer.

 Gemcitabine plus nab-Paclitaxel is one of the standard chemotherapy for metastatic pancreatic adenocarcinoma.

 Gemcitabine plus nab-Paclitaxel realize the favorable anti-tumor effect and tolerable toxicity.

 Gemcitabine plus nab-Paclitaxel is a promising regimen for concurrent chemoradiotherapy, but the investigators need to know the safety in the case of the concurrent chemoradiotherapy.

.

 A Study of Chemoradiotherapy Using Gem Plus Nab-paclitaxel for Pancreatic Cancer@highlight

The purpose of this study is to evaluate the clinical safety and efficacy of Gemcitabine plus nab-Paclitaxel chemoradiotherapy and to determine the Maximal Tolerated Dose (MTD) for unresectable locally advanced pancreatic adenocarcinoma.

